Project Grant W81XWH2210494
Award Date
7/1/22
Completion Date
6/30/26
Dollars Obligated
$5.8M
Federal Agency
Medical Command
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Portland, OR 97239, USA
Similar Awards
The Project Grant award for $897,448.00, awarded on June 1, 2024 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports Oregon Health & Science University's development of "NEXT-GENERATION ELQS FOR LONG-TERM PROTECTION AGAINST MALARIA." This research initiative aims to advance novel treatments and protective measures against malaria, a key focus area for the Defense Health Agency's military medical research initiatives....
The Department of the Army Medical Command awarded a $520,751 Project Grant to the Veteran Research And Education Foundation Of ST Louis through the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from August 1, 2022 to July 31, 2026 to improve outcomes for prostate cancer patients based on comorbidities, with the goal of developing personalized medicine approaches. Through this award, the Foundation will conduct research to investigate medical...
The Department of the Army Medical Command awarded a $157,500 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from June 1, 2021 to May 31, 2022 to restore functional ARF tumor suppression in non-small cell lung carcinoma through the use of peptide mimics. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming...
This Cooperative Agreement award of $638,820 from the Defense Health Agency supports an mRNA multivalent approach to develop an innovative malaria vaccine. The project, funded through the Military Medical Research and Development program (CFDA 12.420), aims to broaden the immune targets against malaria infection by including both pre-erythrocytic-stage antigens and mosquito saliva antigens. The Geneva Foundation, a non-profit research organization, will conduct this research over a 3-year period...
The Department of the Army Medical Command awarded a $1,157,298 cooperative agreement to The Geneva Foundation of Tacoma, WA from September 1, 2022 through August 31, 2025. The award will support research under the Military Medical Research and Development program (CFDA 12.420) to rationally design an immunogen for protection against Plasmodium vivax malaria. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical research,...
The Department of Defense's Defense Health Agency awarded a $393,800 Project Grant to Seattle Children's Hospital, doing business as Seattle Children's Research Institute, to conduct research on "Elucidating Mechanisms of Cell Death in Plasmodium Vivax-Infected Hepatocytes." This grant, provided through the Military Medical Research and Development program (CFDA 12.420), supports basic, translational, and clinical research aimed at developing new treatments, improving patient care, and...
The Department of the Army Medical Command awarded a $1,419,356 project grant to Brigham & Women's Hospital Inc. under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2021 through September 2025 to develop novel immunotherapy approaches to suppress cancer metastasis and recurrence in bone. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of...
The Department of the Army Medical Command awarded New York University School of Medicine a $1,186,500 project grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2021 through August 2024 to understand the transition from nevi to melanoma occurring within the skin epidermis. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military...
The Department of the Army Medical Command has awarded a $5,468,175 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the University of Utah to develop a sustained-release drug delivery device to manage biofilm implant-related infections. The project, with a performance period from May 1, 2024 to April 30, 2028, will involve the University of Utah collaborating with Purgo Scientific LLC as a sub-awardee to advance this innovative medical technology. The...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $5,072,634 project grant to the Regents of the University of Minnesota on Aug 1, 2025. The grant supports the preclinical development of MMV609, a second-generation ATP4i, for malaria. The funding will enable the University of Minnesota to conduct advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. This grant is part of...